1.	Vaccine Therapy in Treating Patients With Metastatic Breast Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00516, MCC16025, CDR0000662733, 108255, NCI8461, MCC-108255, P30CA076292, N01CM62208, NCT01042535
2.	Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011LS109, NCT01560923
3.	1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00268, MCC 15267, N01CM62208, CDR0000576700, MCC-FL065, 15267, 8045, NCT00567931
4.	Phase I Study of 1-Methyl-D-Tryptophan and Docetaxel in Patients With Metastatic Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: MCC-16264, MCC-16264, 8784, NCT01191216
5.	C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Approved-not yet active Age: 18 and older Sponsor: NCI, Other Protocol IDs: NCI 8701, MCC-16216, 8701, NCT01302821